Annexin A1 modulates macula densa function by inhibiting cyclooxygenase 2.

Area of Science:

• Nephrology
• Molecular Biology
• Inflammation Research

Background:

• Annexin A1 (ANXA1) is an anti-inflammatory protein known to interact with formyl peptide receptors (Fpr).
• ANXA1 is present in juxtaglomerular apparatus cells, but its role in regulating cyclooxygenase 2 (COX-2) in the macula densa is unclear.

Purpose of the Study:

• To investigate the hypothesis that ANXA1 regulates COX-2 biosynthesis in the kidney macula densa.
• To elucidate the molecular mechanisms underlying ANXA1's effect on COX-2 expression.

Main Methods:

• Immunohistochemical colocalization of ANXA1 and COX-2 in rat kidneys.
• Analysis of ANXA1 and COX-2 expression in ANXA1-deficient mice.
• In vitro studies using cultured macula densa cells with ANXA1 transfection and dexamethasone treatment.
• Pharmacological inhibition of the ANXA1 receptor Fpr1.

Main Results:

• High colocalization of ANXA1 and COX-2 (95%) in rat macula densa.
• Furosemide treatment increased ANXA1 and COX-2 expression with maintained colocalization.
• ANXA1 deficiency in mice led to increased COX-2 and renin expression.
• ANXA1 transfection and dexamethasone treatment downregulated COX-2 mRNA in cultured cells.
• Fpr1 inhibition blunted dexamethasone's effect on COX-2.

Conclusions:

• ANXA1 exerts an inhibitory effect on COX-2 expression in the macula densa.
• ANXA1 may act as an intrinsic modulator of renal juxtaglomerular regulation through inhibition of prostaglandin E2 synthesis.